Clinical Guidance: Safe Alcohol Practices on GLP-1 Medications General clinical consensus supports moderate alcohol intake (1 drink/day for women, 2 for men) only after the first 48 weeks of GLP-1 therapy
For example, in one animal model, researchers found that a group of fatty acids known as short-chain fatty acids (SCFAs) significantly increase GLP-1 secretion
In your first few weeks, you may notice: Reduced hunger and fewer cravings Feeling full with smaller portions Less preoccupation with food Gradual, steady weight reduction Your dosage is typically increased slowly to help your body adjust comfortably
However, tirzepatide may help support metabolic stability by: Improving blood sugar regulation Supporting fat loss, especially visceral fat Helping preserve lean muscle when paired with strength training and adequate protein intake These factors can support long-term metabolic health even without raising resting calorie burn
Among those factors is an elevated body temperature, called hyperthermia , which has been observed to be linked with an alteration of the permeability of the BBB